imc-001
ImmuneOncia Therapeutics
['rectal', ' epcam', 'gastric', 'colorectal']
icymi: imc001, an investigational car-t therapy targeting epcam, has demonstrated a favorable safety profile and promising anti-tumor activities in patients with advanced colorectal and gastric cancers, according to data presented at #esmo2022 read more: 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.